HighVista Strategies LLC
Filing Date
Global Rank
#2,819
/ 8,232
▲ 75
Top Industry
Biotechnology
68.3%
3Y Alpha vs SPY
+3.1%
Period ended 2 months ago
Filed May 15, 2026 · 30d
25 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+90.1%
SPY
+76.3%
Annualised alpha
+3.1%
Max drawdown
−29.2%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
154 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
8.5%
+2.3 pts
Top 5
18.5%
−0.1 pts
Top 10
27.4%
−1.5 pts
HHI
168
Diversified+5
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 67.4% | $242,385,867 |
| Technology | 9.1% | $32,616,951 |
| Unclassified | 8.5% | $30,607,040 |
| Industrials | 5.5% | $19,810,669 |
| Consumer Cyclical | 2.9% | $10,478,055 |
| Financial Services | 2.3% | $8,419,688 |
| Utilities | 1.7% | $6,148,792 |
| Basic Materials | 0.9% | $3,064,480 |
| Communication Services | 0.6% | $2,210,915 |
| Consumer Defensive | 0.4% | $1,383,251 |
| Real Estate | 0.3% | $1,184,735 |
| Energy | 0.3% | $1,163,975 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| PALI | Palisade Bio, Inc. | +719,295 | 2,019,326 | $3,533,820 | |
| DYN | Dyne Therapeutics, Inc. | +123,286 | 182,929 | $3,316,502 | |
| AMLX | Amylyx Pharmaceuticals, Inc. | +113,273 | 352,085 | $4,893,981 | |
| OCUL | Ocular Therapeutix, Inc | +97,506 | 441,573 | $3,740,123 | |
| TYRA | Tyra Biosciences, Inc. | +96,218 | 131,304 | $5,028,943 | |
| CTMX | CytomX Therapeutics, Inc. | +94,116 | 288,057 | $1,353,867 | |
| ALKS | Alkermes plc. | +46,788 | 73,189 | $2,587,963 | |
| ABVX | Abivax S.A. | +41,069 | 113,254 | $12,610,832 | |
| CORZ | Core Scientific, Inc./tx | +39,900 | 103,412 | $1,547,043 | |
| CLDX | Celldex Therapeutics, Inc. | +37,592 | 89,397 | $2,835,672 | |
| U | Unity Software Inc. | +34,100 | 62,763 | $1,377,020 | |
| LBRX | Lb Pharmaceuticals Inc | +33,488 | 173,595 | $4,280,852 | |
| SLNO | Soleno Therapeutics Inc | +30,158 | 165,227 | $5,531,799 | |
| IMCR | Immunocore Holdings plc | +25,699 | 58,697 | $1,769,714 | |
| CPNG | Coupang, Inc. | +21,244 | 46,036 | $869,159 | |
| BBD | Bank Bradesco | +18,000 | 208,264 | $760,163 | |
| HPE | Hewlett Packard Enterprise Co | +13,800 | 89,981 | $2,142,447 | |
| NOK | Nokia Corp | +11,300 | 70,824 | $569,424 | |
| PCVX | Vaxcyte, Inc. | +10,598 | 124,647 | $7,243,237 | |
| KBR | Kbr, Inc. | +9,400 | 39,406 | $1,452,505 | |
| AXSM | Axsome Therapeutics, Inc. | +9,306 | 20,437 | $3,454,261 | |
| NVDA | Nvidia Corp | +8,200 | 22,420 | $3,910,048 | |
| JANX | Janux Therapeutics, Inc. | +7,940 | 49,383 | $686,423 | |
| AMZN | Amazon Com Inc | +5,000 | 22,397 | $4,664,623 | |
| XEL | Xcel Energy Inc | +4,500 | 12,558 | $997,607 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| VRDN | Viridian Therapeutics, Inc.DE | −238,243 | 134,229 | $2,625,519 | |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | −151,076 | 78,187 | $699,773 | |
| COGT | Cogent Biosciences, Inc. | −139,616 | 197,051 | $7,584,492 | |
| CMPS | COMPASS Pathways plc | −134,573 | 364,360 | $2,014,910 | |
| OLMA | Olema Pharmaceuticals, Inc. | −123,888 | 117,601 | $1,753,430 | |
| RLAY | Relay Therapeutics, Inc. | −123,198 | 421,881 | $4,197,715 | |
| EWTX | Edgewise Therapeutics, Inc. | −79,206 | 91,931 | $2,895,826 | |
| MLYS | Mineralys Therapeutics, Inc. | −77,766 | 46,778 | $1,267,216 | |
| MAZE | Maze Therapeutics, Inc. | −70,503 | 99,850 | $2,980,522 | |
| GPCR | Structure Therapeutics Inc. | −69,092 | 123,909 | $5,972,413 | |
| XOMA | XOMA Royalty Corp | −66,103 | 46,814 | $1,468,555 | |
| PHVS | Pharvaris N.V. | −64,504 | 97,866 | $2,764,714 | |
| TERN | Terns Pharmaceuticals, Inc. | −61,155 | 114,307 | $6,026,265 | |
| LQDA | Liquidia Corp | −56,259 | 99,744 | $3,764,338 | |
| CYTK | Cytokinetics Inc | −55,921 | 58,643 | $3,865,160 | |
| APGE | Apogee Therapeutics, Inc. | −53,468 | 35,761 | $3,010,003 | |
| STOK | Stoke Therapeutics, Inc. | −52,922 | 62,617 | $2,038,809 | |
| TRVI | Trevi Therapeutics, Inc. | −52,634 | 53,525 | $638,553 | |
| RVMD | Revolution Medicines, Inc. | −50,931 | 69,309 | $6,740,300 | |
| RXO | RXO, Inc. | −47,900 | 43,038 | $629,215 | |
| SYRE | Spyre Therapeutics, Inc. | −41,942 | 146,264 | $7,377,556 | |
| PTGX | Protagonist Therapeutics, Inc | −39,693 | 33,852 | $3,568,000 | |
| CNTA | Centessa Pharmaceuticals plc | −38,526 | 5,964 | $236,890 | |
| AVTX | Avalo Therapeutics, Inc. | −37,009 | 58,622 | $875,226 | |
| QXO | QXO, Inc. | −32,400 | 26,320 | $511,134 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ORKA | Oruka Therapeutics, Inc. | 78,911 | $3,870,584 | |
| MLTX | MoonLake Immunotherapeutics | 193,955 | $3,615,321 | |
| DFTX | Definium Therapeutics, Inc. | 185,856 | $3,512,678 | |
| NRIX | Nurix Therapeutics, Inc. | 226,546 | $3,511,463 | |
| IVA | Inventiva S.A. | 615,666 | $3,416,946 | |
| ERAS | Erasca, Inc. | 181,069 | $2,929,696 | |
| XENE | Xenon Pharmaceuticals Inc. | 49,050 | $2,852,257 | |
| VERA | Vera Therapeutics, Inc. | 69,241 | $2,785,565 | |
| ALMS | Alumis Inc. | 112,929 | $2,487,825 | |
| EYPT | EyePoint, Inc. | 183,037 | $2,359,346 | |
| TNGX | Tango Therapeutics, Inc. | 104,193 | $2,179,717 | |
| ASMB | Assembly Biosciences, Inc. | 74,735 | $2,073,896 | |
| JAZZ | Jazz Pharmaceuticals plc | 10,838 | $2,048,923 | |
| NATL | NCR Atleos Corp | 40,100 | $1,747,558 | |
| ON | On Semiconductor Corp | 28,000 | $1,733,760 | |
| KOD | Kodiak Sciences Inc. | 43,569 | $1,660,850 | |
| AVTR | Avantor, Inc. | 186,500 | $1,462,160 | |
| MIRM | Mirum Pharmaceuticals, Inc. | 15,563 | $1,437,709 | |
| SVRA | Savara Inc | 250,999 | $1,370,454 | |
| KNX | Knight-Swift Transportation Holdings Inc. | 22,900 | $1,318,582 | |
| MU | Micron Technology Inc | 3,800 | $1,283,792 | |
| BLTE | Belite Bio, Inc | 8,033 | $1,280,781 | |
| JHX | James Hardie Industries plc | 65,598 | $1,242,426 | |
| KRC | Kilroy Realty Corp | 41,997 | $1,184,735 | |
| STX | Seagate Technology Holdings plc | 2,900 | $1,136,104 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
22 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ACLX | Arcellx, Inc. | 75,002 | $4,890,130 | |
| AGIO | Agios Pharmaceuticals, Inc. | 147,662 | $4,019,359 | |
| APLS | Apellis Pharmaceuticals, Inc. | 150,776 | $3,787,493 | |
| SEPN | Septerna, Inc. | 78,682 | $2,193,654 | |
| APP | AppLovin Corp | 2,482 | $1,672,421 | |
| UNF | Unifirst Corp | 7,727 | $1,490,538 | |
| CMPX | Compass Therapeutics, Inc. | 245,532 | $1,318,506 | |
| TMO | Thermo Fisher Scientific Inc. | 2,269 | $1,314,772 | |
| OFIX | Orthofix Medical Inc. | 85,049 | $1,289,342 | |
| ACHC | Acadia Healthcare Company, Inc. | 81,630 | $1,158,329 | |
| SCHW | Schwab Charles Corp | 10,601 | $1,059,145 | |
| SNDK | Sandisk Corp | 4,378 | $1,039,249 | |
| AFRM | Affirm Holdings, Inc. | 13,086 | $973,990 | |
| VST | Vistra Corp. | 5,673 | $915,225 | |
| BVN | Buenaventura Mining Co Inc | 29,649 | $825,131 | |
| ALC | Alcon Inc | 10,440 | $822,776 | |
| FOUR | Shift4 Payments, Inc. | 12,982 | $817,476 | |
| GTLB | Gitlab Inc. | 19,305 | $724,516 | |
| RBLX | Roblox Corp | 8,431 | $683,163 | |
| CNX | CNX Resources Corp | 17,624 | $648,034 | |
| ALV | Autoliv Inc | 5,243 | $622,344 | |
| DBVT | DBV Technologies S.A. | 15,877 | $304,362 | |
| No positions match the current search. | ||||
154 positions ·
$359,474,418 total
· as of Mar 31, 2026
All sectors
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Showing 1–50
of 154 positions by value
· page 1 of 4
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| DBC |
Invesco DB Commodity Index Tracking Fund
|
Held | 1,057,238 | $30,607,040 | 8.51% | |
| ABVX |
Abivax S.A.
Healthcare
|
Added | 113,254 | $12,610,832 | 3.51% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Added | 26,323 | $8,481,007 | 2.36% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Reduced | 197,051 | $7,584,492 | 2.11% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
Reduced | 146,264 | $7,377,556 | 2.05% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Added | 124,647 | $7,243,237 | 2.01% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Reduced | 69,309 | $6,740,300 | 1.88% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
Reduced | 114,307 | $6,026,265 | 1.68% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Reduced | 123,909 | $5,972,413 | 1.66% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
Reduced | 56,602 | $5,798,874 | 1.61% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
Added | 225,139 | $5,592,452 | 1.56% | |
| SLNO |
Soleno Therapeutics Inc
Healthcare
|
Added | 165,227 | $5,531,799 | 1.54% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
Added | 131,304 | $5,028,943 | 1.40% | |
| AMLX |
Amylyx Pharmaceuticals, Inc.
Healthcare
|
Added | 352,085 | $4,893,981 | 1.36% | |
| AMZN |
Amazon Com Inc
Consumer Cyclical
|
Added | 22,397 | $4,664,623 | 1.30% | |
| LBRX |
Lb Pharmaceuticals Inc
Healthcare
|
Added | 173,595 | $4,280,852 | 1.19% | |
| RLAY |
Relay Therapeutics, Inc.
Healthcare
|
Reduced | 421,881 | $4,197,715 | 1.17% | |
| INSM |
INSMED Inc
Healthcare
|
Reduced | 24,316 | $3,976,152 | 1.11% | |
| NVDA |
Nvidia Corp
Technology
|
Added | 22,420 | $3,910,048 | 1.09% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
NEW | 78,911 | $3,870,584 | 1.08% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Reduced | 58,643 | $3,865,160 | 1.08% | |
| LQDA |
Liquidia Corp
Healthcare
|
Reduced | 99,744 | $3,764,338 | 1.05% | |
| OCUL |
Ocular Therapeutix, Inc
Healthcare
|
Added | 441,573 | $3,740,123 | 1.04% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
Reduced | 52,464 | $3,680,349 | 1.02% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Reduced | 49,560 | $3,680,325 | 1.02% | |
| MLTX |
MoonLake Immunotherapeutics
Healthcare
|
NEW | 193,955 | $3,615,321 | 1.01% | |
| ARGX |
Argenx SE
Healthcare
|
Added | 4,918 | $3,591,369 | 1.00% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Reduced | 33,852 | $3,568,000 | 0.99% | |
| PALI |
Palisade Bio, Inc.
Healthcare
|
Added | 2,019,326 | $3,533,820 | 0.98% | |
| DFTX |
Definium Therapeutics, Inc.
Healthcare
|
NEW | 185,856 | $3,512,678 | 0.98% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
NEW | 226,546 | $3,511,463 | 0.98% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Added | 20,437 | $3,454,261 | 0.96% | |
| IVA |
Inventiva S.A.
Healthcare
|
NEW | 615,666 | $3,416,946 | 0.95% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Added | 182,929 | $3,316,502 | 0.92% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
Reduced | 35,761 | $3,010,003 | 0.84% | |
| GHRS |
GH Research PLC
Healthcare
|
Reduced | 213,212 | $2,997,760 | 0.83% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
Reduced | 35,587 | $2,986,461 | 0.83% | |
| MAZE |
Maze Therapeutics, Inc.
Healthcare
|
Reduced | 99,850 | $2,980,522 | 0.83% | |
| ERAS |
Erasca, Inc.
Healthcare
|
NEW | 181,069 | $2,929,696 | 0.81% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Reduced | 91,931 | $2,895,826 | 0.81% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
Reduced | 73,102 | $2,865,598 | 0.80% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
NEW | 49,050 | $2,852,257 | 0.79% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Added | 89,397 | $2,835,672 | 0.79% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
NEW | 69,241 | $2,785,565 | 0.77% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
Reduced | 97,866 | $2,764,714 | 0.77% | |
| VRDN |
Viridian Therapeutics, Inc.DE
Healthcare
|
Reduced | 134,229 | $2,625,519 | 0.73% | |
| ALKS |
Alkermes plc.
Healthcare
|
Added | 73,189 | $2,587,963 | 0.72% | |
| ALMS |
Alumis Inc.
Healthcare
|
NEW | 112,929 | $2,487,825 | 0.69% | |
| MSFT |
Microsoft Corp
Technology
|
Reduced | 6,457 | $2,390,187 | 0.66% | |
| EYPT |
EyePoint, Inc.
Healthcare
|
NEW | 183,037 | $2,359,346 | 0.66% |